Read more about FDC declines after Q4 PAT slips 16% to Rs 47 cr on Business Standard. FDC fell 4.41% to Rs 332 after the company s consolidated net profit skid 16.3% to Rs 46.76 crore on 6% decline in net sales to Rs 313.40 crore in Q4 March 2021 over Q4 March 2020.
On a consolidated basis, Alkem Laboratories reported 27.1% increase in net profit to Rs 240 crore on 7% increase in revenue from operations to Rs 2192.2 crore in Q4 FY21 over Q4 FY20.
The company s India sales were at Rs 1473.2 crore (up 17.1% YoY) while International sales were at Rs 690.7 crore (down 8.2% YoY) in the fourth quarter.
EBITDA declined 3.9% YoY to Rs 291.1 crore in Q4 FY21. EBITDA margin was at 13.3% as on 31 March 2021 as against 14.8% as on 31 March 2020.
R&D expenses for the quarter was Rs 140.8 crore, or 6.4% of total revenue from operations compared to Rs 125.3 crore in Q4FY20 at 6.1% of total revenue from operations.
Read more about Gland Pharma Q4 PAT rises 34% YoY to Rs 260 cr on Business Standard. The drug maker posted 34% rise in net profit to Rs 260.4 crore on 40% jump in revenue from operations to Rs 887.7 crore in Q4 FY21 over Q4 FY20.
India s cumulative recoveries has surpassed 2 Crore (2,00,79,599, Ministry of Health and Welfare stated on Thursday. The National Recovery Rate is 83.50%. 3,44,776 recoveries were registered in the last 24 hours. It outnumbers India s Daily New COVID cases for the third time in the last four days. Ten states account for 71.16% of the new recoveries. India s total Active Caseload has decreased to 37,04,893 today. It now comprises 15.41% of the country s total Positive Cases. A net decline of 5,632 cases is recorded in the active caseload in the last 24 hours. 12 States cumulatively account for 79.7% of India s total Active Cases.
Government of India continues to expeditiously allocate and deliver global aid to States/UTs through a Whole of Government approach. Cumulatively, 9,294 Oxygen Concentrators; 11,835 Oxygen Cylinders; 19 Oxygen Generation Plants; 6,439 ventilators/Bi PAP and nearly 4.22 L Remdesivir vials delivered/ dispatched through road and air, so far. On the other hand,
Vaishali Pharma reports standalone net loss of Rs 1 45 crore in the March 2021 quarter business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.